China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.360
-0.300 (-11.28%)
At close: Sep 15, 2026, 4:00 PM EDT
2.370
+0.010 (0.42%)
After-hours: Sep 15, 2026, 4:13 PM EDT
China SXT Pharmaceuticals Revenue
In the fiscal year ending March 31, 2026, China SXT Pharmaceuticals had annual revenue of $1.14M, down -34.63%. China SXT Pharmaceuticals had revenue of $511.48K in the half year ending March 31, 2026, a decrease of -48.28%.
Revenue (ttm)
$1.14M
Revenue Growth
-34.63%
P/S Ratio
3.09
Revenue / Employee
$20,322
Employees
56
Market Cap
3.12M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.14M | -602.86K | -34.63% |
| Mar 31, 2025 | 1.74M | -187.59K | -9.73% |
| Mar 31, 2024 | 1.93M | -43.18K | -2.19% |
| Mar 31, 2023 | 1.97M | -630.60K | -24.23% |
| Mar 31, 2022 | 2.60M | -2.18M | -45.53% |
| Mar 31, 2021 | 4.78M | -384.70K | -7.45% |
| Mar 31, 2020 | 5.16M | -1.85M | -26.38% |
| Mar 31, 2019 | 7.01M | -7.22K | -0.10% |
| Mar 31, 2018 | 7.02M | 2.14M | 43.79% |
| Mar 31, 2017 | 4.88M | 1.16M | 31.27% |
| Mar 31, 2016 | 3.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sunshine Biopharma | 35.35M |
| IM Cannabis | 32.25M |
| Sonoma Pharmaceuticals | 21.92M |
| cbdMD | 20.93M |
| InMed Pharmaceuticals | 4.94M |
| Gelteq | 314.70K |
| RedHill Biopharma | 286.00K |
| Akanda | 258.08K |
SXTC News
- 5 weeks ago - China SXT Pharmaceuticals Inc trading halted, news pending - TheFly
- 5 weeks ago - China SXT Pharmaceuticals announces share consolidation - TheFly
- 5 weeks ago - China SXT Pharmaceuticals, Inc. Announces Share Consolidation - GlobeNewsWire
- 7 weeks ago - Univest Securities, LLC Announces Closing of $9 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) - GlobeNewsWire
- 7 weeks ago - China SXT Pharmaceuticals prices 4.5M units at $2.00 in registered direct offer - TheFly
- 7 weeks ago - China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering - GlobeNewsWire
- 5 months ago - China SXT Pharmaceuticals, Inc. Announces Share Re-classification - GlobeNewsWire
- 7 months ago - China SXT Pharmaceuticals Inc trading halted, news pending - TheFly